Skip to content

See the 2023 Shauna M. Sorrells Grant Program winner!

Policy | Funding | Influence

Insights for changemakers on navigating government opportunities.

G2G Blog Banner ARPA-H Feb 2022

Hearing: ARPA-H- The Next Frontier of Biomedical Research

G2G watched the House Energy & Commerce Committee’s Subcommittee on Health hearing on ARPA-H and wanted to share this report.

61d722fcb794fb3f3cbca275_G2G Blog Banner MHSRS Guide Jan 202

MHSRS For Medical Innovators

Are you trying to advance a medical innovation that could be adopted by the military? Read on for insights on the biggest annual military medical conference.

G2G Blog Banner STEM Education Jan 2022 (2)

FY2022 Budget Outlook: STEM Education

The House and Senate have advanced bills that propose steady or increased funding for most major STEM education programs across the federal government in fiscal year 2022. We summarize these upcoming appropriations bills and policy implications here.

61bb54af6889dd1f1f53edfa_BrandiLee and Finn pix

Cancer Advocacy: How You Can Make A Difference for Patients and Families

Individuals and organizations make a big difference when it comes to getting members of Congress to co-sponsor bills or submit requests for appropriations. If you missed our conversation on November 30 detailing ways you can be an advocate for cancer patients and families, read the highlights below and join us for our next guided discussion January 20, 2022.

61a7cfe2cbcf1e48d0851f34_bbb

How Build Back Better Could Impact Your Business

On November 15, President Biden signed into law the $1 trillion infrastructure package that passed both chambers with bipartisan support and includes $550 billion in new spending and $450 billion of redirected unused funds. Here’s our analysis on some of the ways the law can impact your business.

61a7b2748975a24ac9dc797b_BARDA-banner-graphic

BARDA Industry Day 2021 Report

G2G’s summary of the breakout sessions and insights shared during this year’s BARDA Industry Days online conference November 3-4, 2021.